Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients

Greiner, Jochen; Brown, Elliott; Bullinger, Lars; Hills, Robert K.; Morris, Vanessa; Döhner, Hartmut; Mills, Ken I.; Guinn, Barbara Ann

doi:10.3390/ijms221910482

All Outputs (2)

Molecular Mechanisms and Therapies of Myeloid Leukaemia (2022)
Journal Article
Brown, E., & Guinn, B. A. (2022). Molecular Mechanisms and Therapies of Myeloid Leukaemia. International Journal of Molecular Sciences, 23(11), Article 6251. https://doi.org/10.3390/ijms23116251

Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients (2021)
Journal Article
Greiner, J., Brown, E., Bullinger, L., Hills, R. K., Morris, V., Döhner, H., Mills, K. I., & Guinn, B. A. (2021). Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients. International Journal of Molecular Sciences, 22(19), Article 10482. https://doi.org/10.3390/ijms221910482

Abstract: Despite recent advances in therapies including immunotherapy, patients with acute myeloid leukaemia (AML) still experience relatively poor survival rates. The Inhibition of Apoptosis (IAP) family member, survivin, also known by its gene and... Read More about Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients.